Aetiopathology and genetic basis of neonatal diabetes: Table 1

R J Gardner, Emma Wadsworth, Margo L. Whiteford, R S James, David Robinson, J D Baum, I. Karen Temple

Archives of Disease in Childhood Fetal & Neonatal · 1997 · 137 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

A British Paediatric Association Surveillance Unit* study of neonatal diabetes determined a national incidence of 1 in 400,000 live births. Additional cases of transient neonatal diabetes were collected retrospectively. Most cases were of low birthweight at term: none had evidence of an autoimmune aetiopathogenesis. The median requirement for exogenous insulin treatment was three months. A significant number of cases developed type 2 diabetes in later life. Three of the 11 cases were found to have paternal uniparental isodisomy of chromosome 6. A further patient carried an unbalanced duplication of 6q 22-23, inherited from the father, which localised a potentially imprinted gene for diabetes to this region. The fact that low birthweight predisposes to type 2 diabetes in later life is well established, but a genetic defect that may relate both to intrauterine growth failure and the development of type 2 diabetes in later life has now been identified.

References

11